Plasma prostaglandins across the tumor bed of patients with gynecologic malignancy
- 1 May 1977
- Vol. 39 (5) , 2201-2203
- https://doi.org/10.1002/1097-0142(197705)39:5<2201::aid-cncr2820390538>3.0.co;2-9
Abstract
Prostaglandin E produced by tumors has recently been implicated as a mechanism by which tumors may subvert the immune system and grow despite their antigenicity. Arterial and venous determinations of prostaglandin E were performed in eleven patients with gynecologic malignancy. No significant difference was found when arterial and venous levels were compared and there was no difference in venous PGE levels when subjects with cancer were compared to patients with benign gynecologic disease.This publication has 6 references indexed in Scilit:
- Subversion of immune system by tumor cells and role of prostaglandins.Proceedings of the National Academy of Sciences, 1975
- Statistical Quality Control and Routine Data Processing for Radioimmunoassays and Immunoradiometric AssaysClinical Chemistry, 1974
- Antiinflammatory Effects of Murine Malignant CellsProceedings of the National Academy of Sciences, 1974
- Immunosuppressive and immunostimulatory factors produced by malignant cellsIn vitroInternational Journal of Cancer, 1974
- Prostaglandin F in monkey uterine fluid during the menstrual cycle and following steroid treatmentProstaglandins, 1974